2.beta.-Substituted-methylpenicillanic acid derivatives, and sal

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514195, 540310, C07D49900, A61K 31425

Patent

active

048913693

ABSTRACT:
Disclosed are 2.beta.-substituted-methylpenicillanic acid compounds of the formula ##STR1## wherein n is 0, 1 or 2; and ##STR2## is monocyclic or bicyclic heterocyclic ring group which has 2 to 4 nitrogen atoms as hetero atom in its ring structure and which may be optionally substituted with alkyl, alkoxycarbonyl, phenyl, formyl or benzyloxycarbonyl optionally having alkyl, nitro or a halogen atom on the benzene ring, with the proviso that said heterocyclic ring group is not 1,2,3-triazol-1-yl; or salts or esters thereof.
These compounds are useful as .beta.-lactamase inhibitor.

REFERENCES:
patent: 4529592 (1985-07-01), Micetich et al.
patent: 4562073 (1985-12-01), Micetich et al.
patent: 4668514 (1987-05-01), Mictich et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

2.beta.-Substituted-methylpenicillanic acid derivatives, and sal does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2.beta.-Substituted-methylpenicillanic acid derivatives, and sal, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2.beta.-Substituted-methylpenicillanic acid derivatives, and sal will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1383843

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.